BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 9110982)

  • 1. Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination.
    Langermann S; Palaszynski S; Barnhart M; Auguste G; Pinkner JS; Burlein J; Barren P; Koenig S; Leath S; Jones CH; Hultgren SJ
    Science; 1997 Apr; 276(5312):607-11. PubMed ID: 9110982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic immunization with conserved pilus-associated adhesins protects against mucosal infections.
    Palaszynski S; Pinkner J; Leath S; Barren P; Auguste CG; Burlein J; Hultgren S; Langermann S
    Dev Biol Stand; 1998; 92():117-22. PubMed ID: 9554264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli.
    Langermann S; Möllby R; Burlein JE; Palaszynski SR; Auguste CG; DeFusco A; Strouse R; Schenerman MA; Hultgren SJ; Pinkner JS; Winberg J; Guldevall L; Söderhäll M; Ishikawa K; Normark S; Koenig S
    J Infect Dis; 2000 Feb; 181(2):774-8. PubMed ID: 10669375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infection.
    Thankavel K; Madison B; Ikeda T; Malaviya R; Shah AH; Arumugam PM; Abraham SN
    J Clin Invest; 1997 Sep; 100(5):1123-36. PubMed ID: 9276729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transurethral instillation with fusion protein MrpH.FimH induces protective innate immune responses against uropathogenic Escherichia coli and Proteus mirabilis.
    Habibi M; Asadi Karam MR; Bouzari S
    APMIS; 2016 Jun; 124(6):444-52. PubMed ID: 26918627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal immunization with a recombinant truncated FimH adhesin adjuvanted with CpG oligodeoxynucleotides protects mice against uropathogenic Escherichia coli challenge.
    Poggio TV; La Torre JL; Scodeller EA
    Can J Microbiol; 2006 Nov; 52(11):1093-102. PubMed ID: 17215901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination with recombinant FimH fused with flagellin enhances cellular and humoral immunity against urinary tract infection in mice.
    Asadi Karam MR; Oloomi M; Mahdavi M; Habibi M; Bouzari S
    Vaccine; 2013 Feb; 31(8):1210-6. PubMed ID: 23306365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New vaccines may ward off urinary tract infections.
    Service RF
    Science; 1997 Apr; 276(5312):533. PubMed ID: 9148412
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential stability and trade-off effects of pathoadaptive mutations in the Escherichia coli FimH adhesin.
    Weissman SJ; Beskhlebnaya V; Chesnokova V; Chattopadhyay S; Stamm WE; Hooton TM; Sokurenko EV
    Infect Immun; 2007 Jul; 75(7):3548-55. PubMed ID: 17502398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral immunization of piglets with recombinant F4 fimbrial adhesin FaeG monomers induces a mucosal and systemic F4-specific immune response.
    Verdonck F; Cox E; Van der Stede Y; Goddeeris BM
    Vaccine; 2004 Oct; 22(31-32):4291-9. PubMed ID: 15474721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis of tropism of Escherichia coli to the bladder during urinary tract infection.
    Hung CS; Bouckaert J; Hung D; Pinkner J; Widberg C; DeFusco A; Auguste CG; Strouse R; Langermann S; Waksman G; Hultgren SJ
    Mol Microbiol; 2002 May; 44(4):903-15. PubMed ID: 12010488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dimeric and Trimeric Fusion Proteins Generated with Fimbrial Adhesins of Uropathogenic
    Luna-Pineda VM; Reyes-Grajeda JP; Cruz-Córdova A; Saldaña-Ahuactzi Z; Ochoa SA; Maldonado-Bernal C; Cázares-Domínguez V; Moreno-Fierros L; Arellano-Galindo J; Hernández-Castro R; Xicohtencatl-Cortes J
    Front Cell Infect Microbiol; 2016; 6():135. PubMed ID: 27843814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A host receptor enables type 1 pilus-mediated pathogenesis of Escherichia coli pyelonephritis.
    McLellan LK; McAllaster MR; Kim AS; Tóthová Ľ; Olson PD; Pinkner JS; Daugherty AL; Hreha TN; Janetka JW; Fremont DH; Hultgren SJ; Virgin HW; Hunstad DA
    PLoS Pathog; 2021 Jan; 17(1):e1009314. PubMed ID: 33513212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of protective immunity after escherichia coli bladder infection in primates. Dependence of the globoside-specific P-fimbrial tip adhesin and its cognate receptor.
    Söderhäll M; Normark S; Ishikawa K; Karlsson K; Teneberg S; Winberg J; Möllby R
    J Clin Invest; 1997 Jul; 100(2):364-72. PubMed ID: 9218513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal immunization with fusion protein MrpH·FimH and MPL adjuvant confers protection against urinary tract infections caused by uropathogenic Escherichia coli and Proteus mirabilis.
    Habibi M; Asadi Karam MR; Shokrgozar MA; Oloomi M; Jafari A; Bouzari S
    Mol Immunol; 2015 Apr; 64(2):285-94. PubMed ID: 25562574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 1 fimbrial adhesin FimH elicits an immune response that enhances cell adhesion of Escherichia coli.
    Tchesnokova V; Aprikian P; Kisiela D; Gowey S; Korotkova N; Thomas W; Sokurenko E
    Infect Immun; 2011 Oct; 79(10):3895-904. PubMed ID: 21768279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A FimH inhibitor prevents acute bladder infection and treats chronic cystitis caused by multidrug-resistant uropathogenic Escherichia coli ST131.
    Totsika M; Kostakioti M; Hannan TJ; Upton M; Beatson SA; Janetka JW; Hultgren SJ; Schembri MA
    J Infect Dis; 2013 Sep; 208(6):921-8. PubMed ID: 23737602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative differences in adhesiveness of type 1 fimbriated Escherichia coli due to structural differences in fimH genes.
    Sokurenko EV; Courtney HS; Maslow J; Siitonen A; Hasty DL
    J Bacteriol; 1995 Jul; 177(13):3680-6. PubMed ID: 7601831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular variations in Klebsiella pneumoniae and Escherichia coli FimH affect function and pathogenesis in the urinary tract.
    Rosen DA; Pinkner JS; Walker JN; Elam JS; Jones JM; Hultgren SJ
    Infect Immun; 2008 Jul; 76(7):3346-56. PubMed ID: 18474655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Urine Decreases Function and Expression of Type 1 Pili in Uropathogenic Escherichia coli.
    Greene SE; Hibbing ME; Janetka J; Chen SL; Hultgren SJ
    mBio; 2015 Jun; 6(4):e00820. PubMed ID: 26126855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.